Successful Haploidentical Transplant Using Post-Transplant Cyclophosphamide in a Child with Chronic Granulomatous Disease—First Report from the Indian Subcontinent
- 20 January 2021
- journal article
- letter
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 41 (4) , 820-824
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Successful HLA haploidentical hematopoietic SCT in chronic granulomatous diseaseBone Marrow Transplantation, 2014
- Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre studyThe Lancet, 2014
- Chronic granulomatous disease: Overview and hematopoietic stem cell transplantationJournal of Allergy and Clinical Immunology, 2011
- Allogeneic Haematopoietic Stem Cell Transplantation as Therapy for Chronic Granulomatous Disease—Single Centre ExperienceJournal of Clinical Immunology, 2011
- Long-term feto-maternal microchimerism revisitedChimerism, 2010
- Survival after T cell–depleted haploidentical stem cell transplantation is improved using the mother as donorBlood, 2008
- Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: An Italian multicenter studyClinical Immunology, 2008
- G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemiaBone Marrow Transplantation, 2002
- Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000Blood, 2002
- Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.Proceedings of the National Academy of Sciences, 1996